Normally, two standalone procedures are needed to treat both fat and muscle, but now with EMSCULPT NEO this single solution simultaneously melts fat while building muscles. As such, it is a faster, more economical and more efficacious solution than combining multiple procedures. EMSCULPT NEO is a versatile solution that provides inclusivity to most body types; patients up to a BMI of 35 can successfully experience this treatment and its results. 

"There are a great number of benefits that customers will reap after using EMSCULPT NEO. This is a result of us combining the technologies of radio frequency heating to burn fat, and high-intensity focused electromagnetic waves to build muscle," said Ron Borsheim, VP of Product Development of BTL. "Heating the muscles while burning fat allows for synergistic effects that result in more fat reduction and muscle growth than any single gold standard procedure. We are thrilled about the results of seven new clinical studies that show an average of 30% fat reduction and/or 25% increase in muscle mass."

For best results, four treatments are recommended over the course of four weeks.

"While clients are visiting offices for treatments, we are still living in uncertain times, so we know that treatments need to be quick, efficient and worth their time," said John Ferris, VP of US Marketing, of BTL. "EMSCULPT NEO ensures that the client's expectations are exceeded with the results, due to its 2-in-1 solution of burning fat and building muscle at once."

David J. Goldberg, MD, JD shared a similar sentiment when he stated, "It is less time consuming and offers more bang for the buck—with better results. This is the next dimension in body contouring."

"There was a rapid, very measurable, noticeable reduction in fat with an increase in the muscle thickness, and these changes are much better than what we would get alone," shared Carolyn Jacob, MD.

For more information on EMSCULPT NEO and to find a physician near you, please visit www.bodybybtl.com. 

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With 1,900 employees located in more than 58 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

As of September 2020, BTL's European manufacturing facilities have been producing ventilators and masks.  Most recently, FFP2 (European Equivalent to N-95) flat-fit respirator masks, for both medical professionals and consumers. The respirator masks received both an FDA Emergency Use Authorization and a CE Marking.

"There is little doubt that this pandemic has changed the way we all do business.  BTL recognized that as a company, we needed to find a way to help our physicians and partners in the industry.  As a true manufacturer of aesthetic technologies, BTL was able to quickly re-prioritize some of its manufacturing efforts to start building ventilators, respirators and masks to provide support and protection for those who need it most," said Ron Borsheim, VP of Product Development.

"All staff and docs gave these masks a 5-star rating for comfort, breathability, tight seal and ear relief.  Ready to order many more," shared Robert Weiss, MD.

Melanie Palm, MD, FACS stated "I got to tell you, it's a real nice edge up in terms of comfort compared to some of the K95 and N95 respirators. Carolyn Jacob, MD further elaborated "They are more comfortable than any other mask we have been wearing."

More than 1 million masks are currently available for sale at its Massachusetts facility. To inquire or purchase the BTL FFP2 flat-fit healthcare respirator masks please visit: www.bodybybtl.com/masks.

About BTL
Founded in 1993, BTL has grown to become one of the world's major manufacturers of medical and aesthetic equipment. With 1,800 employees located in more than 55 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT, EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

BTL Industries, Inc. ("BTL"), the leading manufacturer of the EMSCULPT body-contouring device and other products for non-invasive body-shaping procedures, filed a complaint today with the United States International Trade Commission ("ITC"), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company ("Allergan"), and Zimmer MedizinSysteme GmbH, Germany ("Zimmer") from importing products that infringe BTL's patents into the United States. BTL concurrently filed a lawsuit with the U.S. Federal District Court in the District of Delaware against Allergan and Zimmer on the same matter.

BTL, the manufacturer behind the revolutionary EMSCULPT technology, is continuing to set-the-pace in aesthetics and non-invasive body shaping and contouring. Today, the brand announced the launch of the new EMSELLA applicator with up to 2.5 Tesla (T) to treat all forms of male and female urinary incontinence. Building upon the existing clearances for the abdomen, buttocks, thighs, arms and calves, the new EMSELLA applicator makes EMSCULPT the first system to treat the whole core; and provide patients with a holistic solution to strengthening their pelvic floor.

“Since launching EMSCULPT in 2018, we’ve seen growing demand from physicians and patients to combine our two innovative and beloved treatments for a complete solution for the whole core,” shared John Ferris, VP of US Marketing, of BTL. “Patients coming for muscle toning are often ideal candidates for pelvic floor treatment.”

The EMSELLA applicator is specially designed to restore neuromuscular control and rehabilitation of weak pelvic muscles. “A 2007 study in The Journal of Women’s Health Physical Therapy concluded over 65% of women who suffer from abdominal separation have a pelvic floor disorder, so we know that there was a need to provide a solution for the whole core,” shared Carolyn Delucia, M.D.

“We can safely infer that using EMSCULPT to treat abdominal separation will complement the EMSELLA treatment. What this all means is that we can take a full-scale surgical mommy makeover, which costs a lot and involve a fair amount of risk, and reduce much of it to two non-invasive treatments that will be much less risky and much less expensive,” said Dr. Delucia. “In addition, the patients who underwent Core to Floor therapy, showed a significant increase in quality of life and often reverted back to activities, like exercising, that that they had forgone prior to treatment.”

For the best results, four 28-minute non-invasive treatments over the course of two weeks are recommended. The EMSCULPT platform delivers the highest amount energy in the treatment area resulting in the strongest muscle contractions induced by non-invasive device on the market.³ For more information on all EMSCULPT applicators and to find a physician near you, please visit www.bodybybtl.com. 

About BTL

Founded in 1993, BTL has grown to become one of the world’s major manufacturers of medical and aesthetic equipment. With 1,800 employees located in more than 55 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women’s intimate health and wellness. BTL’s brands include EMSCULPT, EMSELLA, EMTONE, BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone. Additional information can be found at www.bodybybtl.com.

1. Measured at the coil surface, data on file.
2. https://sciencenordic.com/researcher-zone-sweden/incontinence-affects-more-than-200-million-people-worldwide-so-why-isnt-more-being-done-to-find-a-cure/1454073
3. Average induced current for abdomen, buttocks and leg therapies, data on file.